Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions

Cytotherapy

Volumn 14, Issue 1, 2012, Pages 122-128

  Ilic, Dusko ^a   Stephenson, Emma ^a   Wood, Victoria ^a   Jacquet, Laureen ^a   Stevenson, Danielle ^a   Petrova, Anastasia ^b   Kadeva, Neli ^a   Codognotto, Stefano ^a   Patel, Heema ^a   Semple, Maxine ^c   Cornwell, Glenda ^c   Ogilvie, Caroline ^c   Braude, Peter ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

clinical grade human embryonic stem cells; extracellular matrix; Huntington's disease; myotonic dystrophy type 1

Indexed keywords

ARTICLE; CELL CULTURE; CELL LINE; EMBRYO; EMBRYONIC STEM CELL; GENE MUTATION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MYOTONIC DYSTROPHY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

EID: 83755164231     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.623692     Document Type: Article

References (25)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-7. (Pubitemid 28516247)
2. Stephenson EL, Braude PR, Mason C. International community consensus standard for reporting derivation of human embryonic stem cell lines. Regen Med. 2007;2:349-62. (Pubitemid 47304955)
3. Interim UK Regulatory Route Map for Stem Cell Research and Manufacture, version March 12, 2009. Download available at: www.mhra.gov.uk/Howweregulate/ Medicines/Medicinesregulatorynews/CON041337, accessed on October 13, 2011.
4. Martin MJ, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med. 2005;11:228-32. (Pubitemid 40321360)
5. Salaway T, Ilic D. Logistics of stem cell isolation, preparation and delivery for heart repair: Concerns of clinicians, manufacturers, investors and public health. Regen Med. 2008;3:83-91. (Pubitemid 351541192)
6. Ilic D, Giritharan G, Zdravkovic T, Caceres E, Genbacev O, Fisher SJ, et al. Derivation of human embryonic stem cell lines from biopsied blastomeres on human feeders with minimal exposure to xenomaterials. Stem Cells Dev. 2009;18: 1343-50.
7. Stephenson EL, Braude PR. Derivation of the King' s College London human embryonic stem cell lines. In Vitro Cell Dev Biol Anim. 2010;46:178-85.
8. Skottman H, Narkilahti S, Hovatta O. Challenges and approaches to the culture of pluripotent human embryonic stem cells. Regen Med. 2007;2:265-73. (Pubitemid 46845885)
9. Franklin SB, Hunt C, Cornwell G, Peddie V, Desousa P, Stephenson EL, at al. hESCCO: Development of good practice models for hES cell derivation. Regen Med. 2008;3:105-16. (Pubitemid 351541194)
10. Mann K, Donaghue C, Fox SP, Docherty Z, Ogilvie CM. Strategies for the rapid prenatal diagnosis of chromosome aneuploidy. Eur J Hum Genet. 2004;12:907-15. (Pubitemid 39462124)
11. Ahn JW, Mann K, Walsh S, Shehab M, Hoang S, Docherty Z, et al. Validation and implementation of array comparative genomic hybridisation as a fi rst line test in place of postnatal karyotyping for genome imbalance. Mol Cytogenet 2010;3:9
12. Ilic D, Genbacev O, Krtolica A. Derivation of hESC from intact blastocysts. Curr Protoc Stem Cell Biol. 2007;Chapter 1: Unit 1A.2.
13. Ilic D, Caceres E, Lu S, Julian P, Foulk R, Krtolica A. Effect of karyotype on successful human embryonic stem cell derivation. Stem Cells Dev. 2010;19:39-46.
14. Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD, Lanza R. Human embryonic stem cells derived without feeder cells. Lancet. 2005;365:1636-41. (Pubitemid 40693413)
15. Beacham DA, Amantagelo MD, Cukierman E. Preparation of extracellular matrices produced by cultured and primary fi broblasts. Curr Protoc Cell Biol. 2007;Chapter 10:Unit 10.9.
16. Vlodavsky I. Preparation of extracellular matrices produced by cultured corneal endothelial and PF-HR9 endodermal cells. Curr Protoc Cell Biol. 2001;Chapter 10:Unit 10.4.
17. Heath KE, Day IN, Humphries SE. Universal primer quantitative fl uorescent multiplex (UPQFM) PCR: A method to detect major and minor rearrangements of the low-density lipoprotein receptor gene. J Med Genet. 2000;37:272-80. (Pubitemid 30245932)
18. Renwick PJ, Trussler J, Ostad-Saffari E, Fassihi H, Black C, Braude P, et al. Proof of principle and fi rst cases using preimplantation genetic haplotyping: A paradigm shift for embryo diagnosis. Reprod Biomed Online. 2006;13:110-9. (Pubitemid 44054854)
19. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science. 2001; 294:1708-12. (Pubitemid 33104840)
20. Ilic D. Culture of human embryonic stem cells and the extracellular matrix microenvironment. Regen Med. 2006;1:95-101.
21. www.clinicaltrils.gov (ID: NCT01217008, NCT01345006 and NCT01344993) accessed on October 13, 2011.
22. Fraga AM, Sukoyan M, Rajan P, Braga DP, Iaconelli A Jr, Franco JG Jr, et al. Establishment of a Brazilian line of human embryonic stem cells in defi ned medium: implications for cell therapy in an ethnically diverse population. Cell Transplant. 2011;20:431-40.
23. Mosher JT, Pemberton TJ, Harter K, Wang C, Buzbas EO, Dvorak P, et al. Lack of population diversity in commonly used human embryonic stem-cell lines.nEngl J Med. 2010;362:183-185.
24. Stephenson E, Ogilvie CM, Patel H, Cornwell G, Jacquet L, Kadeva N, Braude P, et al. Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. J R Soc Interface. 2010;7(Suppl 6):S677 - 88.
25. Stephenson E, Ogilvie CM, Patel H, Cornwell G, Jacquet L, Kadeva N, et al. Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. J R Soc Interface. 2010;7(Suppl 6):S677 - 88.